Alpha- glucosidase blev udpeget som lægemiddel til sjældne sygdomme den 14. februar 2001.
Because the number of patients with Pompe disease is low, the disease is considered ‘ rare’, and Myozyme was designated as an ‘ orphan medicine ’ (a medicine used in rare diseases) on 14 February 2001.